Welcome to our dedicated page for Stevanato Group S.p.A. news (Ticker: $STVN), a resource for investors and traders seeking the latest updates and insights on Stevanato Group S.p.A. stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Stevanato Group S.p.A.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Stevanato Group S.p.A.'s position in the market.
Stevanato Group S.p.A. reported financial results for Q1 2024, with revenue decreasing by 1% to €236.0 million. The company adjusted its fiscal year 2024 guidance due to industry destocking and postponed orders, expecting revenue between €1,125 million to €1,155 million. Despite challenges, the company remains confident in its strong fundamentals and growth potential in biologics. The BDS segment revenue grew by 2% to €198.9 million, while the Engineering segment revenue decreased by 13% to €37.1 million. The company raised net proceeds of €170.5 million in a public offering, maintaining mid-term targets for fiscal years 2025 to 2027.
Stevanato Group, a global leader in drug containment, drug delivery, and diagnostic solutions, will participate in the Bank of America Securities Healthcare Conference from May 14 to May 16, 2024. The Company will present on May 15, 2024, at 11:20 a.m. (PT). A live webcast will be accessible on the Company's website, with a replay available for 90 days.